| 000 | 01625 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515104043.0 | ||
| 264 | 0 | _c20080205 | |
| 008 | 200802s 0 0 eng d | ||
| 022 | _a0003-9950 | ||
| 024 | 7 |
_a10.1001/archophthalmol.2007.23 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSaab, Georges | |
| 245 | 0 | 0 |
_aReversible cystoid macular edema secondary to fingolimod in a renal transplant recipient. _h[electronic resource] |
| 260 |
_bArchives of ophthalmology (Chicago, Ill. : 1960) _cJan 2008 |
||
| 300 |
_a140-1 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Clinical Trial, Phase III; Letter | ||
| 650 | 0 | 4 |
_aCyclosporine _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFingolimod Hydrochloride |
| 650 | 0 | 4 | _aFluorescein Angiography |
| 650 | 0 | 4 |
_aGraft Rejection _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xsurgery |
| 650 | 0 | 4 | _aKidney Transplantation |
| 650 | 0 | 4 |
_aMacular Edema _xchemically induced |
| 650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
| 650 | 0 | 4 |
_aPropylene Glycols _xadverse effects |
| 650 | 0 | 4 |
_aSphingosine _xadverse effects |
| 650 | 0 | 4 | _aTomography, Optical Coherence |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 700 | 1 | _aAlmony, Arghavan | |
| 700 | 1 | _aBlinder, Kevin J | |
| 700 | 1 | _aSchuessler, Rebecca | |
| 700 | 1 | _aBrennan, Daniel C | |
| 773 | 0 |
_tArchives of ophthalmology (Chicago, Ill. : 1960) _gvol. 126 _gno. 1 _gp. 140-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/archophthalmol.2007.23 _zAvailable from publisher's website |
| 999 |
_c17703587 _d17703587 |
||